An integrated analysis of thirteen trials summarizing thelong-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy-Reference-Cited by-同舟云学术

An integrated analysis of thirteen trials summarizing thelong-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy

Published:2005-12 Issue:12 Volume:27 Page:1912-1921
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Goffe Bernard,Papp Kim,Gratton David,Krueger Gerald G.,Darif Mohamed,Lee Sophia,Bozic Carmen,Sweetser Marianne T.,Ticho Barry

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Treatment of psoriasis. Part 2. Systemic therapies;Lebwohl;J Am Acad Dermatol,2001

2. Cyclosporine consensus conference: With emphasis on the treatment of psoriasis;Lebwohl;J Am Acad Dermatol,1998

3. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study;Stern;J Natl Cancer Inst,1998

4. The role of T cells in psoriasis;Prinz;J Eur Acad Dermatol Venereol,2003

5. Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis;Ortonne;Eur J Dermatol,2003

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Guidelines for Managing Patients With Psoriasis on Biologics: An Update;Journal of Cutaneous Medicine and Surgery;2019-01

2. Psoriasis Therapy: Breakthroughs in Pharmacogenomics or in Pharmacology?;Journal of Investigative Dermatology;2016-12

3. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial;Clinical Therapeutics;2016-06

4. Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety;Drug Safety;2015-04-02

5. Immune Compromise Associated with Biologics;Stiehm's Immune Deficiencies;2014